Schering-Plough
SGP
#544
Rank
HK$361.32 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Revenue for Schering-Plough (SGP)

Revenue in 2008: HK$144.73 Billion

In 2008 the company made a revenue of HK$144.73 Billion.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Schering-Plough from 1996 to 2008

Annual revenue

Year Revenue Change
2008HK$144.73 B
2006HK$82.87 B11.42%
2005HK$74.37 B14.94%
2004HK$64.70 B-0.74%
2003HK$65.19 B-18.13%
2002HK$79.63 B3.86%
2001HK$76.67 B-0.13%
2000HK$76.77 B6.96%
1999HK$71.77 B13.61%
1998HK$63.18 B19.16%
1997HK$53.02 B19.84%
1996HK$44.24 B